{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:31:48Z","timestamp":1792009908562,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.xcrm.2024.101884","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:40:42Z","timestamp":1736178042000},"page":"101884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Associations between multiple metabolic biomarkers with steatotic liver disease subcategories: A 5-year Chinese cohort study"],"prefix":"10.1016","volume":"6","author":[{"given":"Hongli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yebei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huating","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-2168","authenticated-orcid":false,"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101884_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2024.101884_bib2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155800","article-title":"Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up","volume":"153","author":"Choe","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.xcrm.2024.101884_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","article-title":"Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study","volume":"9","author":"Israelsen","year":"2024","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/HEP.0000000000000664","article-title":"Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2024.101884_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.xcrm.2024.101884_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diabres.2007.08.016","article-title":"Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"79","author":"Wu","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.xcrm.2024.101884_bib8","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2007-0209","article-title":"Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes","volume":"92","author":"Jia","year":"2007","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2024.101884_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2012.10.029","article-title":"High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China","volume":"58","author":"Li","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-021-01351-1","article-title":"FGF21\/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China","volume":"20","author":"Liu","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.xcrm.2024.101884_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/aps.2017.23","article-title":"Association of bone turnover markers with glucose metabolism in Chinese population","volume":"38","author":"Wang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.xcrm.2024.101884_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2337\/dc21-2113","article-title":"Osteocalcin and Risks of Incident Diabetes and Diabetic Kidney Disease: A 4.6-Year Prospective Cohort Study","volume":"45","author":"Ye","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101884_bib14","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/aps.2015.81","article-title":"Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels","volume":"36","author":"Luo","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.xcrm.2024.101884_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1119005","article-title":"The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease","volume":"10","author":"Qin","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2024.101884_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc06-2342","article-title":"High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans","volume":"30","author":"Stefan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2024.101884_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","article-title":"Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease","volume":"68","author":"Seo","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101884_bib18","article-title":"Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101884_bib19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jbmr.4227","article-title":"Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models","volume":"36","author":"Xia","year":"2021","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.xcrm.2024.101884_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115871","article-title":"AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review","volume":"218","author":"Barbalho","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2024.101884_bib21","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in\u00a0NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101884_bib22","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1021\/acs.jmedchem.9b00352","article-title":"Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis","volume":"62","author":"Cioffi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2024.101884_bib23","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101884_bib24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101884_bib25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jhep.2020.08.028","article-title":"The times they are a-changin' (for NAFLD as well)","volume":"73","author":"Ratziu","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/edrv-10-3-308","article-title":"Retinol-binding protein: the serum transport protein for vitamin A","volume":"10","author":"Blaner","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xcrm.2024.101884_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101884_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diabet.2019.04.009","article-title":"Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease","volume":"46","author":"Wang","year":"2020","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.xcrm.2024.101884_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat\u00a0mass","volume":"6","author":"Kl\u00f6ting","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101884_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101884_bib32","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101884_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101884_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","article-title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance","volume":"19","author":"Moraes-Vieira","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101884_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111312","article-title":"Retinol-binding protein 4 in obesity and metabolic dysfunctions","volume":"531","author":"Nono Nankam","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101884_bib36","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/hep.28659","article-title":"Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice","volume":"64","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2024.101884_bib37","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/hep.28722","article-title":"Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease","volume":"64","author":"Romeo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2024.101884_bib38","doi-asserted-by":"crossref","first-page":"15269","DOI":"10.1074\/jbc.RA118.004294","article-title":"Liver-secreted RBP4 does not impair glucose homeostasis in mice","volume":"293","author":"Fedders","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2024.101884_bib39","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1152\/ajpendo.90526.2008","article-title":"Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue","volume":"296","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.xcrm.2024.101884_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2265.2008.03295.x","article-title":"Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis","volume":"70","author":"Bahr","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.xcrm.2024.101884_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic Messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2024.101884_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.xcrm.2024.101884_bib43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101884_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041180","article-title":"Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition","volume":"13","author":"Khoramipour","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.xcrm.2024.101884_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/138955706777435689","article-title":"Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease","volume":"6","author":"M\u00e9ndez-S\u00e1nchez","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.xcrm.2024.101884_bib46","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","article-title":"Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver","volume":"19","author":"Musso","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2024.101884_bib47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MEG.0000000000000535","article-title":"Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men","volume":"28","author":"Yang","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000369789","article-title":"Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women","volume":"91","author":"Sinn","year":"2015","journal-title":"Digestion"},{"key":"10.1016\/j.xcrm.2024.101884_bib49","article-title":"Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study","volume":"15","author":"Chen","year":"2024","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101884_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","article-title":"Guidelines for the assessment and management\u00a0of non-alcoholic fatty liver disease in the Asia-Pacific region:\u00a0executive summary","volume":"22","author":"Farrell","year":"2007","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101884_bib51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2024.101884_bib52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124006554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:10:54Z","timestamp":1740888654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124006554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2666379124006554"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101884","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between multiple metabolic biomarkers with steatotic liver disease subcategories: A 5-year Chinese cohort study","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101884"}}